Related Experiment Video
Updated: Jan 30, 2026

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
Published on: June 20, 2020
Characteristics of Cases of Prescription Fentanyl Exposure Among US Children Aged <6 Years Reported to Poison
Keisuke Abe1, Lynne Fullerton2, Samuel Swift3
1Wesley Medical Center, Wichita, KS, USA.
Insights
Prescription fentanyl exposure in children under 6 decreased significantly from 2015-2024, despite rising illicit fentanyl cases. Safe disposal and caregiver education are crucial for preventing pediatric exposure to prescription fentanyl.
Area of Science:
- Pediatric toxicology
- Pharmaceutical safety
- Public health surveillance
Background:
- Illicit fentanyl exposure in US children has risen over the past decade.
- Trends in prescription fentanyl exposure among young children remain largely unknown.
- Understanding prescription fentanyl exposure patterns is vital for targeted prevention strategies.
Purpose of the Study:
- To describe trends and characteristics of prescription fentanyl exposure in children under 6 years old.
- To analyze geographic patterns of prescription fentanyl exposure across the US.
- To compare prescription fentanyl exposure rates with trends in illicit fentanyl exposure.
Main Methods:
- Analysis of prescription fentanyl exposure cases in children <6 years reported to the National Poison Data System (NPDS) from 2012-2024.
- Descriptive statistics to characterize exposure demographics, formulations, and geographic distribution.
- Joinpoint trend analysis to identify significant changes in exposure rates over time.
Main Results:
- A total of 376 prescription fentanyl exposure cases were reported in children <6 years.
- Children under 2 years old accounted for 61.5% of exposures, with transdermal patches being the most common formulation (53.7%).
- Prescription fentanyl exposure significantly decreased annually by 7.9% from 2015-2024 (P<.05).
Conclusions:
- Despite increasing illicit fentanyl exposures, prescription fentanyl exposures in young children have declined since 2015.
- Safe disposal of prescription fentanyl transdermal patches is critical.
- Enhanced caregiver education is necessary to prevent adverse outcomes from pediatric prescription fentanyl exposure.
Objectives:
Illicit fentanyl exposure among US children has increased in the past 10 years. However, whether rates of prescription fentanyl exposure have changed in this population is unknown. We described prescription fentanyl exposure among young children.
Methods:
We studied cases of prescription fentanyl exposure among children aged <6 years that were reported to the National Poison Data System (NPDS) from 2012 through 2024. We described the characteristics of prescription fentanyl exposure and US geographic patterns. We used binomial tests, the Pearson χ2 test, and joinpoint trend analysis with a type I error rate of .05 as the threshold for significance.
Results:
From 2012 through 2024, a total of 376 cases of prescription fentanyl exposure among children aged <6 years were reported to NPDS. Boys (n = 179; 47.6%) and girls (n = 196; 52.1%) were equally represented (P = .48). Significantly more children aged <2 years than aged 2 to 6 years in our study group had prescription fentanyl exposure (61.5%; P < .001), and the most common formulation was transdermal patch (n = 202; 53.7%). Joinpoint trend analysis showed a slight but not significant increase in prescription fentanyl exposure among children aged <6 years from 2012 through 2015. However, from 2015 through 2024, prescription fentanyl exposure significantly decreased (annual percentage change = -7.9; P < .05). The state with the highest annual exposure rate from prescription fentanyl was Vermont (4.3 per 1 million population).
Conclusions:
From 2015 through 2024, during a time of increasing exposure to illicit fentanyl, prescription fentanyl exposure among children aged <6 years decreased. Safe disposal of transdermal patches is important, and caregiver education is needed to prevent serious medical outcomes.
Related Concept Videos
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Prevention of Further Absorption of Poison
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Characteristics of Life
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...

